The global multiple sclerosis drugs market size was valued at USD 26.39 billion in 2024 and is projected to reach from USD 27.37 billion in 2025 to USD 36.6 billion by 2033, growing at a CAGR of 3.7% during the forecast period (2025-2033). How Is the Multiple Sclerosis Drugs Market Analyzed and What Research Methodology Is Used? The study examines...

Introduction The rheumatoid arthritis market is witnessing steady growth due to the increasing prevalence of autoimmune diseases and advancements in treatment options. Rheumatoid arthritis is a chronic inflammatory disorder that primarily affects joints but can also impact other systems in the body. It requires long-term management and treatment, making it a significant area of focus in the...

The TCR Therapy Market is experiencing rapid transformation due to groundbreaking advances in immunotherapy and genetic engineering. This dynamic sector is at the forefront of personalized cancer treatments and immune-related disorder interventions, with innovations reshaping market growth strategies. Increasing investments in research and successful clinical trials are propelling business...